Dentin matrix acidic phosphoprotein 1 (DMP1)

Dentin matrix acidic phosphoprotein 1 (DMP1) is an extracellular matrix protein in the SIBLING family, essential for the correct mineralization of bone and dentin[1][3][4][8]. Highly phosphorylated, with numerous acidic domains and a cell attachment motif, DMP1 is expressed in various bone and tooth cell types[1][3][5]. In undifferentiated osteoblasts, unphosphorylated DMP1 functions as a nuclear transcriptional activator for osteoblast-specific genes, such as osteocalcin[1][3]. Upon osteoblast maturation, it becomes phosphorylated and is exported to the extracellular matrix, where it regulates the nucleation and organization of hydroxyapatite, thus orchestrating proper mineralization[1][3][4]. Mutations in the DMP1 gene cause autosomal recessive hypophosphatemia, manifesting clinically as rickets and osteomalacia due to abnormal phosphate homeostasis and defective mineralized tissue formation[1][3][7]. DMP1 also plays a protective, anti-apoptotic role in ameloblasts and odontoblasts, particularly under conditions of phosphate imbalance[7]. The protein is highly post-translationally modified, further suggesting regulatory complexity in tooth and bone formation[2][5][8]. Although essential for tissue mineralization, DMP1 is not a therapeutic target (such as a receptor, transporter, enzyme, or similar pharmacologic target). No direct interacting drugs or mechanisms of action relevant to pharmacotherapy have been described to date[1][3][5]. However, it is clinically relevant as a genetic and biochemical biomarker for understanding, diagnosing, and researching disorders of mineralization in bone and teeth[1][7].

Other names

DMP1DMP-1Dentin matrix protein 1ARHPARHRdentin matrix acidic phosphoprotein 1dentin matrix protein 1